PMCF Retrospective Study Outcomes of a Premium Monofocal IOL

Inclusion Criteria: * • Male or female adults ages 45 years or older on the day of treatment that were mono- or bilaterally implanted with Isopure 1.2.3. intraocular lens minimum 120 days before the study visit; * Maximum time between first and second eye treatment: 45 days (this accounts for bilateral implantations only); * Capability to understand and sign an IRB approved informed consent form and privacy authorization; * Clear intraocular media; * Minimum set of retrospective preoperative and intraoperative data available as outlined in the examination matrix; * Willing and able to conform to the study requirements. Exclusion Criteria: * • Age of patient \<45 years at the day of surgery; * Time between first and second eye treatment: \>45 days (this accounts for bilateral implantations only); * Subjects who underwent previous intraocular or corneal surgery other than IOL implantation; * Subjects with diagnosed degenerative visual disorders (e.g. AMD or CME); * Subjects in whom in-the-bag implantation was not possible; * Subjects in whom surgical complications occurred (e.g. posterior rupture). * Subjects showing glaucoma;